Gam Holding Ag Reata Pharmaceuticals Inc Transaction History

Gam Holding Ag

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 26, 2022	SELL	$25.61 - $110.96 $46,430 - $201,170	-1,813 Reduced 6.73%	25,146 $663,000
Q2 2021 Aug 09, 2021	SELL	$78.27 - $151.29 $324,116 - $626,491	-4,141 Reduced 13.32%	26,959 $3.82 Million
Q1 2021 May 10, 2021	BUY	$94.25 - $132.81 $2.93 Million - $4.13 Million	31,100 New	31,100 $3.1 Million
Q4 2020 Feb 10, 2021	SELL	$102.03 - $184.62 $6.81 Million - $12.3 Million	-66,750 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$124.16 - $247.74 $558,720 - $1.11 Million	-4,500 Reduced 6.32%	66,750 $9.64 Million
Q4 2019 Feb 06, 2020	SELL	$74.57 - $217.92 $1.48 Million - $4.31 Million	-19,800 Reduced 21.75%	71,250 $14.6 Million
Q1 2019 May 10, 2019	BUY	$51.9 - $101.79 $1.85 Million - $3.63 Million	35,650 Added 64.35%	91,050 $7.78 Million
Q4 2018 Feb 08, 2019	BUY	$48.76 - $76.44 $39,008 - $61,152	800 Added 1.47%	55,400 $3.11 Million
Q3 2018 Nov 13, 2018	BUY	$35.64 - $92.06 $302,940 - $782,510	8,500 Added 18.44%	54,600 $4.46 Million
Q2 2018 Aug 09, 2018	BUY	$19.94 - $40.96 $919,234 - $1.89 Million	46,100 New	46,100 $1.61 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.